Figure 5
Figure 5. Schema of E1411. Maintenance therapy is administered for 2 years. B, bendamustine; R, rituximab; V, bortezomib.

Schema of E1411. Maintenance therapy is administered for 2 years. B, bendamustine; R, rituximab; V, bortezomib.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal